Home / Inspections / 1311620

FDA Inspection 1311620 — American Red Cross Blood Services

American Red Cross Blood Services — FEI 1373023

The FDA completed an inspection of American Red Cross Blood Services on March 24, 2026 in Liverpool, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 24, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Liverpool, NY (United States)

Facility

Other inspections at this facility

  • 1191449 (NAI Mon Nov 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1006529 (NAI Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 943002 (NAI Wed Sep 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 845259 (NAI Mon Aug 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 735936 (NAI Fri Jul 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources